| Assessing the Effectiveness of 2D Non-Navigated Intraoperative Ultrasound in Glioma Surgery (NCT05873946) | Hospital del Rio Hortega | 2018-06-01 |
| Analysis of Circulating Tumor Markers in Blood (NCT04025541) | Institut du Cancer de Montpellier - Val d'Aurelle | 2018-05-29 |
| A Biospecimen Collection Study in BRAF-V600E Mutated Recurrent Gliomas (NCT03593993) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2018-05-19 |
| Long Term Follow up of Patients Under 5 Years of Age With High Grade Glioma Diagnosed in France Between 1990 and 2015 (NCT03690570) | University Hospital, Strasbourg, France | 2018-05-09 |
| Trial of IDH305 in IDH1 Mutant Grade II or III Glioma (NCT02977689) | NYU Langone Health | 2018-04-01 |
| Evaluation of Functional Magnetic Resonance Imaging (fMRI) in Patients Who Speak Two Languages Fluently (NCT03496181) | Memorial Sloan Kettering Cancer Center | 2018-03-30 |
| Validation of Readiband™ Actigraph and Associated Sleep/Wake Classification Algorithms (NCT03877861) | Allina Health System | 2018-03-15 |
| SJDAWN: St. Jude Children's Research Hospital Phase 1 Study Evaluating Molecularly-Driven Doublet Therapies for Children and Young Adults With Recurrent Brain Tumors (NCT03434262) | St. Jude Children's Research Hospital | 2018-03-05 |
| Personalized Chimeric Antigen Receptor T Cell Immunotherapy for Patients With Recurrent Malignant Gliomas (NCT03423992) | Xuanwu Hospital, Beijing | 2018-03-02 |
| Hydroxy-urea and Temozolomide in Patients With a Recurrent Malignant Brain Tumor (Glioblastoma) (NCT03463733) | M.E. van Linde | 2018-03-02 |
| Autologous CAR-T/TCR-T Cell Immunotherapy for Malignancies (NCT03638206) | Shenzhen BinDeBio Ltd. | 2018-03-01 |
| Seizure Treatment in Glioma (NCT03048084) | Leiden University Medical Center | 2018-02-01 |
| Proton Beam or Intensity-Modulated Radiation Therapy in Preserving Brain Function in Patients With IDH Mutant Grade II or III Glioma (NCT03180502) | NRG Oncology | 2018-01-23 |
| A Study of Apatinib in Recurrent or Recurrent High-grade Glioma (NCT03390062) | West China Hospital | 2018-01-04 |
| Survival Significance of Molecular Pathology and Genetic Variation in Brain Gliomas (NCT04216537) | The First Affiliated Hospital of Zhengzhou University | 2018-01-01 |
| Safety Study of VAL-083 and Radiotherapy in Patients With Newly Diagnosed GBM Having Unmethylated MGMT Expression (NCT03050736) | Kintara Therapeutics, Inc. | 2017-12-17 |
| MR Perfusion Methods in Patients With Suspected Recurrent High Grade Gliomas (NCT02919865) | Ottawa Hospital Research Institute | 2017-12-13 |
| Study of Dasatinib in Combination With Everolimus for Children and Young Adults With Gliomas Harboring Platelet-Derived Growth Factor Receptor (PDGFR) Alterations (NCT03352427) | University of Michigan Rogel Cancer Center | 2017-12-06 |
| Intratumorally-Administered Topotecan Using CED in High Grade Glioma Undergoing Stereotactic Biopsy (NCT03193463) | Michael Vogelbaum, MD, PhD | 2017-11-03 |
| VAL-083 Phase 3 Study in Temozolomide-Avastin (Bevacizumab) Recurrent GBM (NCT03149575) | DelMar Pharmaceuticals, Inc. | 2017-10-27 |
| Cognitive Remediation Therapy for Brain Tumor Patients: Improving Working Memory (NCT03323450) | Virginia Commonwealth University | 2017-10-20 |
| The Utility of 18F-DOPA-PET in the Treatment of Recurrent High-grade Glioma (NCT03242824) | Mayo Clinic | 2017-09-29 |
| A Study of the Treatment of Recurrent Malignant Glioma With rQNestin34.5v.2 (NCT03152318) | Dana-Farber Cancer Institute | 2017-07-18 |
| Optune® Plus Bevacizumab in Bevacizumab-Refractory Recurrent Glioblastoma (NCT02743078) | RTOG Foundation, Inc. | 2017-05-09 |
| Trial of Selumetinib in Patients With Neurofibromatosis Type II Related Tumors (NCT03095248) | Children's Hospital Medical Center, Cincinnati | 2017-05-08 |
| Neural Stem Cell Based Virotherapy of Newly Diagnosed Malignant Glioma (NCT03072134) | Northwestern University | 2017-04-24 |
| Resting-State Functional MRI in Glioma Patients Before and After Surgery (NCT03964909) | M.D. Anderson Cancer Center | 2017-04-24 |
| Development of Therapeutic Approaches Modulating Molecular Targets Implicated on Cancer Stem Cell-related Aggressiveness (NCT06348693) | Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico | 2017-04-19 |
| Study of NovoTTF-200A Alone and With Temozolomide in Patients With Low-Grade Gliomas (NCT02507232) | Santosh Kesari | 2017-04-17 |
| A Study of Varlilumab and IMA950 Vaccine Plus Poly-ICLC in Patients With WHO Grade II Low-Grade Glioma (LGG) (NCT02924038) | Nicholas Butowski | 2017-04-03 |
| GliomaAI-Astro23: MRI-Based Detection of IDH Mutant Astrocytoma (Grade 2 and 3) (NCT07673666) | Deep Learning Institute of Radiological Sciences | 2017-03-14 |
| GliomaAI-GBM: MRI-Based Detection of IDH Wildtype Glioblastoma (NCT07673692) | Deep Learning Institute of Radiological Sciences | 2017-03-14 |
| GliomaAI-Oligo: MRI-Based Detection of IDH Mutant Oligodendroglioma (NCT07673705) | Deep Learning Institute of Radiological Sciences | 2017-03-14 |
| GliomaAI-MG: MRI-Based Detection of Molecular Glioblastoma (NCT07664254) | Deep Learning Institute of Radiological Sciences | 2017-03-14 |
| GliomaAI-Astro4: MRI-Based Detection of IDH Mutant Astrocytoma Grade 4 (NCT07673679) | Deep Learning Institute of Radiological Sciences | 2017-03-14 |
| Improving Ultrasound Images in Brain Tumour Surgery With the Use of an Acoustic Coupling Fluid Mimicking Brain Tissue. (NCT03181581) | St. Olavs Hospital | 2017-03-01 |
| A Microdose Evaluation Study of ABY-029 in Recurrent Glioma (NCT02901925) | Dartmouth-Hitchcock Medical Center | 2017-02-13 |
| [11C]Acetate PET in Patients With Glioma (NCT02986815) | University of Texas Southwestern Medical Center | 2017-01-24 |
| Study of VAL-083 in Patients With MGMT Unmethylated, Bevacizumab-naive Glioblastoma in the Adjuvant or Recurrent Setting (NCT02717962) | Kintara Therapeutics, Inc. | 2017-01-20 |
| Study of DS-1001b in Patients With Gene IDH1-Mutated Gliomas (NCT03030066) | Daiichi Sankyo | 2017-01-19 |
| GlucoCEST MRI in Oncology (NCT03212157) | University College, London | 2017-01-06 |
| Histopathology Images Based Prediction of Molecular Pathology in Glioma Using Artificial Intelligence (NCT04217044) | The First Affiliated Hospital of Zhengzhou University | 2017-01-01 |
| Phase 2 Study of IDH305 in Low Grade Gliomas (NCT02987010) | University of Texas Southwestern Medical Center | 2017-01-01 |
| Histopathology Images Based Survival Prediction of Glioma Patients Using Artificial Intelligence (NCT04215224) | The First Affiliated Hospital of Zhengzhou University | 2017-01-01 |
| Disulfiram in Recurrent Glioblastoma (NCT02678975) | Sahlgrenska University Hospital | 2017-01-01 |
| The Research on 89Zr-ABT806 PET Imaging in High Grade Glioma (NCT03058198) | Huashan Hospital | 2017-01-01 |
| MR Based Prediction of Molecular Pathology in Glioma Using Artificial Intelligence (NCT04217018) | The First Affiliated Hospital of Zhengzhou University | 2017-01-01 |
| MR Based Survival Prediction of Glioma Patients Using Artificial Intelligence (NCT04215211) | The First Affiliated Hospital of Zhengzhou University | 2017-01-01 |
| Magnetic Resonance Elastography in Glioma: Exploring Tumor Stiffness and Adhesion (NCT05990244) | Shengjing Hospital | 2017-01-01 |
| H3.3K27M Peptide Vaccine With Nivolumab for Children With Newly Diagnosed DIPG and Other Gliomas (NCT02960230) | Sabine Mueller, MD, PhD | 2016-11-18 |
| Intraoperative Ultrasound Guided Glioma Surgery; a Randomised, Controlled Trial. (NCT03531333) | Erasmus Medical Center | 2016-11-01 |
| A Toll-like Receptor Agonist as an Adjuvant to Tumor Associated Antigens (TAA) Mixed With Montanide ISA-51 VG With Bevacizumab for Patients With Recurrent Glioblastoma (NCT02754362) | NYU Langone Health | 2016-11-01 |
| Foci of Tumor Heterogeneity in Diffuse Low-Grade Gliomas (NCT04423094) | University Hospital, Montpellier | 2016-11-01 |
| Neo-adjuvant Evaluation of Glioma Lysate Vaccines in WHO Grade II Glioma (NCT02549833) | Jennie Taylor | 2016-10-17 |
| Image-Based Quantitative Assessment of Acute Radiation-Induced Changes in Glioma (NCT03168919) | University of Alabama at Birmingham | 2016-10-06 |
| Combination Adenovirus + Pembrolizumab to Trigger Immune Virus Effects (NCT02798406) | DNAtrix, Inc. | 2016-10-06 |
| Multimodality Imaging Combined With Multiple Targets Pathological Examination for Detecting of Biological Borders of Gliomas: a Clinical Application Study (NCT02941302) | General Hospital of Ningxia Medical University | 2016-10-01 |
| A Study of High-Dose Chemoradiation Using Biologically-Based Target Volume Definition in Patients With Glioblastoma (NCT02805179) | University of Michigan Rogel Cancer Center | 2016-09-22 |
| Study of a c-Met Inhibitor PLB1001 in Patients With PTPRZ1-MET Fusion Gene Positive Recurrent High-grade Gliomas (NCT02978261) | Beijing Pearl Biotechnology Limited Liability Company | 2016-09-01 |
| A Nomogram for Predicting the Diagnosis of Central Malignant Tumors Based on Preoperative Clinical Characteristics and Laboratory Indicators: (NCT06914700) | Guangdong Provincial People's Hospital | 2016-09-01 |
| Temozolomide Chronotherapy for High Grade Glioma (NCT02781792) | Washington University School of Medicine | 2016-08-11 |
| Erlotinib in Combination With Temozolomide in Treating Relapsed/Recurrent/Refractory Pediatric Solid Tumors (NCT02689336) | Washington University School of Medicine | 2016-08-06 |
| nTMS for Motor Mapping of Rolandic Lesions (NCT02879682) | Technical University of Munich | 2016-08-01 |
| Feasibility And Efficacy Of An iPad-Based Cognitive Rehabilitation Program In Brain Tumor Patients (NCT02783495) | University of California, San Francisco | 2016-07-19 |
| Study on Neuroepithelial Tumor Grading and Pseudoprogression After Glioma Therapy Using Advanced Functional MRI Techniques (NCT02622620) | Tang-Du Hospital | 2016-07-01 |
| Trial of Panobinostat in Children With Diffuse Intrinsic Pontine Glioma (NCT02717455) | Pediatric Brain Tumor Consortium | 2016-06-28 |
| Differentiation of Progression From Treatment Effects in High-Grade Gliomas: A Clinical Trial With Multimodality MR Imaging (NCT03102203) | Jinling Hospital, China | 2016-06-08 |
| Delayed 18F-FDG PET/CT in Improving Visualization of Brain Tumors in Patients With Glioblastoma (NCT02919332) | Jonsson Comprehensive Cancer Center | 2016-06-08 |
| Study About the Validity of MRS-guided Resection on Prognosis High-grade Glioma Gliomas (NCT02795364) | Huashan Hospital | 2016-06-01 |
| Hemostasis Alterations in Neurosurgical Patients (NCT02652897) | Santiago R. Leal-Noval | 2016-05-01 |
| Whole-Brain Tumor Burden Metrics with Inflammatory and Molecular Markers to Predict Postoperative Neurocognitive Decline in Glioma (NCT06885333) | West China Hospital | 2016-05-01 |
| Qualitative, Qualitative, and Functional Studies Over the First Year in Measuring Immune System Response During the First Year of Therapy in Patients With Brain Tumors (NCT02747407) | Wake Forest University Health Sciences | 2016-05-01 |
| Early-Phase Study to Assess Inhibitor Ribociclib in Patients With Recurrent Glioblastoma or Anaplastic Glioma (NCT02345824) | University of Virginia | 2016-03-01 |
| Bevacizumab and Ascorbic Acid in Patients Treating With Recurrent High Grade Glioma (NCT02833701) | University of Nebraska | 2016-03-01 |
| A Clinical Research of CAR T Cells Targeting HER2 Positive Cancer (NCT02713984) | Zhi Yang | 2016-03-01 |
| Safety and Efficacy of IDH1R132H-DC Vaccine in Gliomas (NCT02771301) | Hebei Yanda Hospital | 2016-02-01 |
| Pembrolizumab (MK-3475) in Patients With Recurrent Malignant Glioma With a Hypermutator Phenotype (NCT02658279) | Memorial Sloan Kettering Cancer Center | 2016-01-22 |
| IRDye800CW-BBN PET-NIRF Imaging Guiding Surgery in Patients With Lower Grade Glioma (NCT03407781) | Deling Li | 2016-01-01 |
| Radiomics for Prediction of Survival in GBM (NCT02666066) | Maastricht Radiation Oncology | 2016-01-01 |
| Supratotal Resection for Gliomas Within Noneloquent Areas (NCT02676687) | Southwest Hospital, China | 2016-01-01 |
| Hyperpolarized Imaging in Diagnosing Participants With Glioma (NCT03739411) | Susan Chang | 2015-12-09 |
| Registry Study on Epidemiological and Biological Disease Profile as Well as Clinical Outcome in Patients With Low Grade Gliomas (NCT02686229) | University of Ulm | 2015-11-15 |
| Metformin And Chloroquine in IDH1/2-mutated Solid Tumors (NCT02496741) | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 2015-11-01 |
| Study of the IDO Pathway Inhibitor, Indoximod, and Temozolomide for Pediatric Patients With Progressive Primary Malignant Brain Tumors (NCT02502708) | NewLink Genetics Corporation | 2015-10-01 |
| Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial) (NCT02465060) | National Cancer Institute (NCI) | 2015-08-17 |
| Using MRI-Guided Laser Heat Ablation to Induce Disruption of the Peritumoral Blood Brain Barrier to Enhance Delivery and Efficacy of Treatment of Pediatric Brain Tumors (NCT02372409) | Washington University School of Medicine | 2015-08-14 |
| 11C-Methionine PET as Prognostic Marker of Gliomas (NCT02518061) | Istituto Clinico Humanitas | 2015-07-01 |
| Wild-Type Reovirus in Combination With Sargramostim in Treating Younger Patients With High-Grade Relapsed or Refractory Brain Tumors (NCT02444546) | Mayo Clinic | 2015-06-21 |
| Maximum Tolerated Dose, Safety, and Efficacy of Rhenium Nanoliposomes in Recurrent Glioma (ReSPECT) (NCT01906385) | Plus Therapeutics | 2015-06-03 |
| Study of Orally Administered AG-881 in Patients With Advanced Solid Tumors, Including Gliomas, With an IDH1 and/or IDH2 Mutation (NCT02481154) | Institut de Recherches Internationales Servier | 2015-06-01 |
| Sedatives' Effects on Neurological Function in Patients With Eloquent Area Glioma (NCT02439164) | Beijing Tiantan Hospital | 2015-05-26 |
| Non Invasive Measurements of Intracranial Pressure in Patients With Malignant Glioma (NCT02520492) | Centre Jean Perrin | 2015-04-03 |
| Non Invasive Detection of IDH1/2 Mutation in Gliomas (NCT02597335) | Assistance Publique - Hôpitaux de Paris | 2015-04-01 |
| Feasibility and Clinically Application of Magnetic Resonance Fingerprinting (NCT02387840) | Case Comprehensive Cancer Center | 2015-03-01 |
| Identification of Genomic Changes in Families Having Multiple Members With Tumors (NCT02386241) | St. Joseph's Hospital and Medical Center, Phoenix | 2015-03-01 |
| Remote Brain Microhaemorrhages May Predict Haematoma in Glioma Patients Treated With Radiation Therapy (NCT03973892) | Fondation Ophtalmologique Adolphe de Rothschild | 2015-01-01 |
| Longitudinal Prospective Study of Neurocognition & Neuroimaging in Primary BT Patients (NCT05576103) | Jona Hattangadi-Gluth | 2015-01-01 |
| 68Ga-NOTA-Aca-BBN(7-14) PET/CT in Patients With Primary Gliomas (NCT02520882) | Peking Union Medical College Hospital | 2015-01-01 |
| Study of Orally Administered Enasidenib (AG-221) in Adults With Advanced Solid Tumors, Including Glioma, or Angioimmunoblastic T-cell Lymphoma, With an IDH2 Mutation (NCT02273739) | Celgene | 2014-12-08 |
| Assistance in Neurosurgery (ExtempoRMN) (NCT02272452) | University Hospital, Strasbourg, France | 2014-10-01 |